Severe autoimmune hemolytic anemia during pegylated interferon plus ribavirin treatment for chronic hepatitis C: a case report

We report a rare case of severe autoimmune hemolytic anemia triggered by pegylated interferon during combination therapy for chronic HCV. This case demonstrated that interferon can de novo induce autoimmune hemolytic anemia during therapy for chronic hepatitis C in a previously healthy patient.

Detalles Bibliográficos
Autores principales: Wang, Shasha, Qin, Eryun, Zhi, Yixiao, Hua, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5582272/
https://www.ncbi.nlm.nih.gov/pubmed/28878911
http://dx.doi.org/10.1002/ccr3.1098
_version_ 1783261155114876928
author Wang, Shasha
Qin, Eryun
Zhi, Yixiao
Hua, Rui
author_facet Wang, Shasha
Qin, Eryun
Zhi, Yixiao
Hua, Rui
author_sort Wang, Shasha
collection PubMed
description We report a rare case of severe autoimmune hemolytic anemia triggered by pegylated interferon during combination therapy for chronic HCV. This case demonstrated that interferon can de novo induce autoimmune hemolytic anemia during therapy for chronic hepatitis C in a previously healthy patient.
format Online
Article
Text
id pubmed-5582272
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-55822722017-09-06 Severe autoimmune hemolytic anemia during pegylated interferon plus ribavirin treatment for chronic hepatitis C: a case report Wang, Shasha Qin, Eryun Zhi, Yixiao Hua, Rui Clin Case Rep Case Reports We report a rare case of severe autoimmune hemolytic anemia triggered by pegylated interferon during combination therapy for chronic HCV. This case demonstrated that interferon can de novo induce autoimmune hemolytic anemia during therapy for chronic hepatitis C in a previously healthy patient. John Wiley and Sons Inc. 2017-07-27 /pmc/articles/PMC5582272/ /pubmed/28878911 http://dx.doi.org/10.1002/ccr3.1098 Text en © 2017 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Wang, Shasha
Qin, Eryun
Zhi, Yixiao
Hua, Rui
Severe autoimmune hemolytic anemia during pegylated interferon plus ribavirin treatment for chronic hepatitis C: a case report
title Severe autoimmune hemolytic anemia during pegylated interferon plus ribavirin treatment for chronic hepatitis C: a case report
title_full Severe autoimmune hemolytic anemia during pegylated interferon plus ribavirin treatment for chronic hepatitis C: a case report
title_fullStr Severe autoimmune hemolytic anemia during pegylated interferon plus ribavirin treatment for chronic hepatitis C: a case report
title_full_unstemmed Severe autoimmune hemolytic anemia during pegylated interferon plus ribavirin treatment for chronic hepatitis C: a case report
title_short Severe autoimmune hemolytic anemia during pegylated interferon plus ribavirin treatment for chronic hepatitis C: a case report
title_sort severe autoimmune hemolytic anemia during pegylated interferon plus ribavirin treatment for chronic hepatitis c: a case report
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5582272/
https://www.ncbi.nlm.nih.gov/pubmed/28878911
http://dx.doi.org/10.1002/ccr3.1098
work_keys_str_mv AT wangshasha severeautoimmunehemolyticanemiaduringpegylatedinterferonplusribavirintreatmentforchronichepatitiscacasereport
AT qineryun severeautoimmunehemolyticanemiaduringpegylatedinterferonplusribavirintreatmentforchronichepatitiscacasereport
AT zhiyixiao severeautoimmunehemolyticanemiaduringpegylatedinterferonplusribavirintreatmentforchronichepatitiscacasereport
AT huarui severeautoimmunehemolyticanemiaduringpegylatedinterferonplusribavirintreatmentforchronichepatitiscacasereport

Ejemplares similares